Lise Geissert

4 Patents

• US125459282026

  Machine Methods to Determine Neoepitope Payload Toxicity

  Nantbio, Inc.

  0 cites
• US124486382025

  Enzyme Based System for Production of Messenger RNA with Increased Transfection Efficiency

  Immunitybio, Inc.

  0 cites
• US122905582025

  Sars-cov-2 Vaccines Comprising Human Adenovirus Vectors Encoding Spike and Nucleocapsid-etsd Immunogens

  Immunitybio, Inc.

  0 cites
• US118576202024

  Method of Inducing Immunity Against Sars-cov-2 Using Spike (s) and Nucleocapsid (N)-ETSD Immunogens Delivered by a Replication-defective Adenovirus

  Immunitybio, Inc.

  0 cites